J-shaped relationship between cardiovascular risk and efficacy of intensive blood pressure reduction: A post-hoc analysis of the SPRINT trial
Table 3
Primary and secondary outcomes in patients with a 10-year Framingham cardiovascular risk score >7%.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Primary and secondary outcomes in patients with a 10-year Framingham cardiovascular risk score >7%.